Apotex Asks Fed. Circ. To Toss $76M AstraZeneca IP Win
Generic-drug maker Apotex Corp. pushed a Federal Circuit panel Monday to overturn AstraZeneca AB's $76 million award for Apotex's infringement of two patents for the indigestion drug Prilosec, claiming the royalty...To view the full article, register now.
Already a subscriber? Click here to view full article